Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-01-21 @ 3:28 PM
Study NCT ID:
NCT01411267
Status:
COMPLETED
Last Update Posted:
2022-04-04
First Post:
2011-08-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AC220 for Children With Relapsed/Refractory ALL or AML
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-01
First Submit QC Date:
None
Study First Post Date:
2011-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-03
Results First Submit QC Date:
None
Results First Post Date:
2020-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-04-04
Last Update Post Date Type:
ACTUAL